Vonakis Becky M, Saini Sarbjit S
Department of Medicine, Division of Allergy and Clinical Immunology, The Johns Hopkins University School of Medicine, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Room 2A.52, Baltimore, MD 21224, USA.
Curr Allergy Asthma Rep. 2005 Jul;5(4):270-6. doi: 10.1007/s11882-005-0066-0.
Chronic idiopathic urticaria (CIU) is diagnosed in patients when urticarial eruptions recur for more than 6 weeks, and no specific cause is determined. Given that urticaria resembles the lesions induced by injection of histamine or allergen into the skin, a role for mast cells or basophils has been proposed in the generation of localized urticarial lesions. However, currently, the exact mechanisms governing regional mast cell or basophil activation are unknown. In the past decade, there has been mounting interest in viewing CIU as an autoimmune disease, given the presence of circulating autoantibodies to IgE or the alpha subunit of the high-affinity IgE receptor (FceRI) in a subset of patients. In this review, we propose that in addition to autoantibodies, specific differences in the expression of FceRI-signaling molecules in the basophils or mast cells of CIU patients may contribute to the generation of urticarial eruptions.
慢性特发性荨麻疹(CIU)是在荨麻疹皮疹复发超过6周且未确定具体病因的患者中诊断出来的。鉴于荨麻疹类似于将组胺或变应原注射到皮肤中所诱发的皮损,有人提出肥大细胞或嗜碱性粒细胞在局限性荨麻疹皮损的产生中起作用。然而,目前尚不清楚调控局部肥大细胞或嗜碱性粒细胞活化的确切机制。在过去十年中,鉴于一部分患者体内存在针对IgE或高亲和力IgE受体(FceRI)α亚基的循环自身抗体,人们越来越倾向于将CIU视为一种自身免疫性疾病。在本综述中,我们提出,除自身抗体外,CIU患者嗜碱性粒细胞或肥大细胞中FceRI信号分子表达的特定差异可能有助于荨麻疹皮疹的产生。